Expression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinoma
Tóm tắt
Từ khóa
Tài liệu tham khảo
El-Serag, 2004, Hepatocellular carcinoma: Recent trends in the United States, Gastroenterology, 127, S27, 10.1053/j.gastro.2004.09.013
Ferlay, 2010, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, Int J Cancer, 127, 2893, 10.1002/ijc.25516
Jin, 1998, Cancer survival in Shanghai, People's Republic of China, IARC Sci Publ, 145, 37
Lee, 2006, The expression patterns of deubiquitinating enzymes, USP22 and Usp22, Gene Expr Patterns, 6, 277, 10.1016/j.modgep.2005.07.007
Zhang, 2008, The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression, Mol Cell, 29, 102, 10.1016/j.molcel.2007.12.015
Zhang, 2008, USP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A, Cell Cycle, 7, 1522, 10.4161/cc.7.11.5962
Liu, 2010, Implication of USP22 in the regulation of BMI-1, c-Myc, p16INK4a, p14ARF, and cyclin D2 expression in primary colorectal carcinomas, Diagn Mol Pathol, 19, 194, 10.1097/PDM.0b013e3181e202f2
Zhang, 2011, Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer, J Cancer Res Clin Oncol, 137, 1245, 10.1007/s00432-011-0998-9
Tang, 2015, High USP22 expression indicates poor prognosis in hepatocellular carcinoma, Oncotarget, 6, 12654, 10.18632/oncotarget.3705
Atanassov, 2009, Gcn5 and SAGA regulate shelterin protein turnover and telomere maintenance, Mol Cell, 35, 352, 10.1016/j.molcel.2009.06.015
Atanassov, 2011, USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1, EMBO Rep, 12, 924, 10.1038/embor.2011.140
Uren, 1996, Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors, Proc Natl Acad Sci USA, 93, 4974, 10.1073/pnas.93.10.4974
Yang, 2004, Cell division and cell survival in the absence of survivin, Proc Natl Acad Sci USA, 101, 15100, 10.1073/pnas.0406665101
Ambrosini, 1997, A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma, Nat Med, 3, 917, 10.1038/nm0897-917
Peters, 2006, The anaphase promoting complex/cyclosome: A machine designed to destroy, Nat Rev Mol Cell Biol, 7, 644, 10.1038/nrm1988
Li, 2014, CUL9 mediates the functions of the 3M complex and ubiquitylates survivin to maintain genome integrity, Mol Cell, 54, 805, 10.1016/j.molcel.2014.03.046
Connell, 2008, Nuclear survivin has reduced stability and is not cytoprotective, J Biol Chem, 283, 3289, 10.1074/jbc.M704461200
Glinsky, 2005, Death-from-cancer signatures and stem cell contribution to metastatic cancer, Cell Cycle, 4, 1171, 10.4161/cc.4.9.2001
Glinsky, 2005, Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer, J Clin Invest, 115, 1503, 10.1172/JCI23412
Glinsky, 2006, Genomic models of metastatic cancer: Functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated Polycomb Group (PcG) protein chromatin silencing pathway, Cell Cycle, 5, 1208, 10.4161/cc.5.11.2796
Sowa, 2009, Defining the human deubiquitinating enzyme interaction landscape, Cell, 138, 389, 10.1016/j.cell.2009.04.042
Piao, 2013, Increased expression of USP22 is associated with disease progression and patient prognosis of salivary duct carcinoma, Oral Oncol, 49, 796, 10.1016/j.oraloncology.2013.03.454
Ning, 2012, Overexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancer, Eur J Histochem, 56, e46, 10.4081/ejh.2012.e46
Piao, 2012, USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma, PLoS One, 7, e42540, 10.1371/journal.pone.0042540
Liu, 2012, USP22 acts as an oncogene by the activation of BMI-1-mediated INK4a/ARF pathway and Akt pathway, Cell Biochem Biophys, 62, 229, 10.1007/s12013-011-9287-0
Lin, 2012, USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development, Mol Cell, 46, 484, 10.1016/j.molcel.2012.03.024
Honda, 2003, Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis, Mol Biol Cell, 14, 3325, 10.1091/mbc.E02-11-0769
Beardmore, 2004, Survivin dynamics increases at centromeres during G2/M phase transition and is regulated by microtubule-attachment and Aurora B kinase activity, J Cell Sci, 117, 4033, 10.1242/jcs.01242
Peroukides, 2010, Survivin overexpression in HCC and liver cirrhosis differentially correlates with p-STAT3 and E-cadherin, Histol Histopathol, 25, 299
Morinaga, 2004, Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma, Oncol Rep, 12, 1189
Qi, 2010, Nuclear Survivin expression is correlated with malignant behaviors of head and neck cancer together with Aurora-B, Oral Oncol, 46, 263, 10.1016/j.oraloncology.2010.01.004
Qi, 2009, Intracellular localization of survivin determines biological behavior in colorectal cancer, Oncol Rep, 22, 557
Tuncel, 2012, Nuclear Aurora B and cytoplasmic survivin expression is involved in lymph node metastasis of colorectal cancer, Oncol Lett, 3, 1109, 10.3892/ol.2012.633
Hori, 2013, The detergent-soluble cytoplasmic pool of survivin suppresses anoikis and its expression is associated with metastatic disease of human colon cancer, PLoS One, 8, e55710, 10.1371/journal.pone.0055710
Acquati, 2013, Epigenetic regulation of survivin by Bmi1 is cell type specific during corticogenesis and in gliomas, Stem Cells, 31, 190, 10.1002/stem.1274